May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Five–Year Incidence of Blindness from Retinopathy of Prematurity
Author Affiliations & Notes
  • S. Ciaccia
    Ophthalmology and Visual Science, Univ Hosp San Raffaele Milano, Milano, Italy
  • M. Ibarra
    Eye Institute Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • A. Capone
    Eye Institute Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • M. Trese
    Eye Institute Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • Footnotes
    Commercial Relationships  S. Ciaccia, None; M. Ibarra, None; A. Capone, None; M. Trese, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3526. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Ciaccia, M. Ibarra, A. Capone, M. Trese; Five–Year Incidence of Blindness from Retinopathy of Prematurity . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3526.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To report the incidence of blindness from retinopathy of prematurity (ROP) at a single medical center from January 1993 through December 1997. Methods: A retrospective chart review of a consecutive series of inborn babies managed with a consistent treatment protocol for laser and vitrectomy at the William Beaumont Hospital, Royal Oak, Michigan. All children were screened at less than 31 weeks postmenstrual age (PMA) or 4 weeks after birth. Retinopathy was graded by the International Classification of Retinopathy of Prematurity. Results: 1452 eyes of 726 patients met inclusion criteria and were screened. 80 eyes (5.5%) of 40 patients reached threshold for laser treatment per the CryoROP study definition of stage 3 threshold disease. Of the 80 eyes treated with laser, 5 eyes underwent lens–sparing vitrectomy (LSV) for predominantly tractional stage 4A ROP, 1 eye underwent LSV for predominantly tractional stage 4B ROP and, in the single patient with bilateral stage 5 ROP, 1 eye underwent lensectomy–vitrectomy (LV) and the fellow eye underwent LV and scleral buckling. The child with bilateral stage 5 ROP was lost to follow–up, leaving 6 eyes with complete follow–up. 5 of these 6 eyes (83%) had reattached retinas; the remaining eye's retina could not be reattached and resulted in no–light–perception (NLP) vision. The single NLP eye represents 1.25% of eyes reaching stage 3 ROP threshold, or 0.07% of all eyes that were screened. Conclusions:Among a large sample of patients at risk for ROP, the screening and treatment protocol at our institution yielded a low rate of blindness. For those eyes that reached stage 3 threshold disease, the incidence of blindness from acute ROP was 1.25%.

Keywords: retinopathy of prematurity • retinal detachment • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×